Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:47:42 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



T:CRDL - CARDIOL THERAPEUTICS INC. CL 'A' - http://cardiolrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRDL - T  0.42.92·3.110.12.93-0.29-9.0295.18657413.22  3.27  2.923.27  0.7716:00:00May 1415 min RT 2¢
TSX - T0.42.92·3.110.12.93-0.29-9.0191.45663893.22  3.27  2.923.27  0.7716:00:0015 min
NEO ATS - U 2.96-0.26-8.19.827473.24  3.24  2.9415:54:3215 min
Alpha - A 2.92-0.30-9.311.635113.24  3.24  2.9215:31:0415 min
Omega - O 2.93-0.29-9.02.56163.22  3.22  2.9315:59:5615 min
Pure - P 2.93-0.29-9.02.25223.10  3.10  2.9215:59:5615 min
Chi-X - X 2.96-0.26-8.133.197793.24  3.24  2.9215:55:5115 min
CX2 - H 2.97-0.25-7.842.41241363.24  3.24  2.9315:59:4915 min
CXD - D 2.95-0.27-8.40.92233.00  3.00  2.9515:41:5815 min
TriAct - M 3.221.0316    Sep 11-2015 min
CS2 - S 3.02-0.20-6.20.2123.01  3.02  3.0114:11:0415 min

Recent Trades - Last 10 of 741
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:15:02X3.08-0.1410057 Interactive79 CIBC
16:15:02X3.08-0.1410057 Interactive79 CIBC
16:15:02X3.08-0.1410057 Interactive79 CIBC
16:00:00T2.93-0.29785 Citadel57 InteractiveQ
16:00:00T2.93-0.29125 Citadel57 InteractiveQ
16:00:00T2.93-0.29665 Citadel57 InteractiveQ
16:00:00T2.93-0.29765 Citadel57 InteractiveQ
16:00:00T2.93-0.29365 Citadel57 InteractiveQ
16:00:00T2.93-0.29515 Citadel57 InteractiveQ
16:00:00T2.93-0.29615 Citadel57 InteractiveQ

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-14 17:07C:CRDL2.95SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-14 17:07C:CRDL2.95SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-17 13:49C:CRDL2.415Warrants ExpireCardiol Therapeutics warrants to expire May 13
2024-04-02 09:26C:CRDL2.58News ReleaseCardiol Therapeutics recaps 2023 operations
2024-04-01 19:04C:CRDL2.58SEDAR Annual ReportSEDAR Annual Report
2024-04-01 18:57C:CRDL2.58SEDAR MD & ASEDAR MD & A
2024-04-01 18:45C:CRDL2.58SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-21 11:23C:CRDL2.25News ReleaseCardiol completes patient enrolment for CardiolRx study
2024-02-15 09:28C:CRDL1.42News ReleaseCardiol receives orphan drug designation for CardiolRx
2024-01-24 11:08C:CRDL1.52News ReleaseCardiol regains Nasdaq listing standard compliance
2024-01-09 11:35C:CRDL1.36News ReleaseCardiol enrolls over 50% of patients in Archer study
2023-12-05 11:11C:CRDL1.29News ReleaseCardiol adds Mass. General Hospital to CardiolRx study
2023-11-16 09:18C:CRDL1.14News ReleaseCardiol presents CardiolRx study results at MPD2023
2023-11-14 16:45C:CRDL1.19SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 16:41C:CRDL1.19SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-01 10:27C:CRDL1.17News ReleaseCardiol enrolls over 50% of patients in CardiolRx study
2023-10-20 17:16C:CRDL0.94News ReleaseCardiol's share price sinks below Nasdaq $1 (U.S.) min.
2023-10-10 10:00C:CRDL1.18News ReleaseCardiol's CRD-38 study shows cardioprotective effects
2023-09-19 10:39C:CRDL1.31News ReleaseCardiol expects full enrolment in Archer phase 2 trial
2023-08-10 17:07C:CRDL1.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements